Security key
19243B102
COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX)
CUSIP: 19243B102
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 11,168,930
- Total 13F value
- $3,463,844
- Share change
- -447,851
- SEC-reported price per share
- $0.31
- Number of holders
- 45
- Value change
- -$159,050
- Number of buys
- 16
- Number of sells
- 16
- Shares outstanding
- 87,819,638
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
45
Top holders
10
CGTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
COGNITION THERAPEUTICS INC SEC filings
COGNITION THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 19243B102
Recent filing periods:
Ownership snapshot
Top reported holders of CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Leslie W. Kreis
Disclosed value leader
BIOS Capital Management, LP
Comparable rows
15/15
Latest evidence
18 Jun 2025
3/4/5
13F
Lead comparable stake: 6.9%
Showing 1-6 of 15 holder rows.
Quick read
Leslie W. Kreis leads the comparable SEC ownership view at 6.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Leslie W. Kreis's linked filing trail.
Comparable ownership
Top 5
Leslie W. Kreis
6.9%
BIOS Capital Management, LP
6.8%
VANGUARD GROUP INC
1.4%
ACADIAN ASSET MANAGEMENT LLC
1.1%
Sigma Planning Corp
0.69%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Leslie W. Kreis |
3/4/5
Director, 10%+ Owner
|
6.9%
|
$1,572,603
6,048,500 shares
|
— | 18 Jun 2025 |
| BIOS Capital Management, LP |
13F
Company
|
6.8%
|
$2,524,800
6,000,000 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
1.4%
|
$521,689
1,239,167 shares
|
— | 31 Mar 2025 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
1.1%
|
$422,000
1,007,586 shares
|
— | 31 Mar 2025 |
| Sigma Planning Corp |
13F
Company
|
0.69%
|
$256,011
608,390 shares
|
— | 31 Mar 2025 |
| Voss Capital, LP |
13F
Company
|
0.51%
|
$189,360
450,000 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
45
Shares
11,168,930
Rows available
45
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
48
Q2 2025 holders
45
Holder diff
-3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend